by Kimberley Peck | Sep 1, 2022 | Blog, MHRA
Following the MHRA and Commitees of Advertising Practice (CAP) releasing a joint enforcement notice regarding advertising Kenalog injections for an unlicenced use, are you as a wholesaler or end user such as clinic aware of the rules around advertising medicines?
by Kimberley Peck | Aug 23, 2022 | Blog, MHRA, WDA(H)
Is your scope of Wholesale Distribution Authorisation (WDA) out of date? – Are you aware that the Wholesale Distribution Authorisation (WDA) categories have changed?
by Steven Hewison | Aug 23, 2022 | Blog, MHRA
Separation of the Licence Holder and Responsible Person – The last paragraph on page 128 of the 2017 Green Guide contained the following sentence:
In the case of small companies, the licensing authority may accept the licence holder as the nominated RP.
by Amelia Holmes | Aug 5, 2022 | Blog, MHRA
The main concerns with regard to possible defects of medicinal products and the substances used in their manufacture or packaging.
by Thomas Currie | Jul 28, 2022 | Blog, MHRA
Medicinal products seized within the week running from the 23rd-30th June, the Medicines and Healthcare products Regulatory Agency (MHRA) seized 285,000 medicines and medical devices which were valued at almost £1,000,000.
by Amelia Holmes | Jul 13, 2022 | Blog, MHRA, WDA(H), WDA(H)
Import Licensed Human Medicine – Prior to importation of a licensed medicine applications for the relevant Licence(s) must be completed and submitted which may include one or more of the following: